ATH alterity therapeutics limited

Ann: Phase 2 DMC Recommends Continuing Clinical Trial as Planned, page-6

  1. 273 Posts.
    lightbulb Created with Sketch. 128
    I think you might be a little confused there @FiveCent. The -202 trial results are due out sometime in the next 7 weeks. The -201 trial results are due in January '25. The -201 trial recruited its first patient in early May '23, so has been going for 12 months now, not 4, but it is good to see that for the 3rd time, the DMC recommends continuing with the -201 trial as planned.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.000(0.00%)
Mkt cap ! $147.3M
Open High Low Value Volume
1.7¢ 1.8¢ 1.5¢ $787.6K 48.96M

Buyers (Bids)

No. Vol. Price($)
13 9250665 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 6931087 13
View Market Depth
Last trade - 16.11pm 28/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.